Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Washington University Medical School, St Louis, MO, USA.
J Shoulder Elbow Surg. 2023 Aug;32(8):1618-1628. doi: 10.1016/j.jse.2023.02.120. Epub 2023 Mar 11.
Bariatric surgery (BS) is a debated, yet commonly used, management strategy in the treatment of morbidly obese patients. Despite recent advances in BS techniques, there is limited data on the potential impact of prior BS in patients undergoing shoulder arthroplasty. This investigation evaluated the outcomes of primary shoulder arthroplasty (SA) in patients with prior BS when compared to matched controls.
Over a 31-year period (1989-2020), 183 primary SA (12 hemiarthroplasties [HAs], 59 anatomic total shoulder arthroplasties [aTSAs], and 112 reverse shoulder arthroplasties [RSAs]) in patients with prior BS and a minimum of 2-year follow-up had been performed at a single institution. This cohort was matched 1:1:1 according to age, sex, diagnosis, implant, American Society of Anesthesiologists score, Charlson Comorbidity Index, and SA surgical year to separate control groups of SA with no history of BS and a BMI of either <40 (low BMI group) or ≥40(high BMI group). Surgical complications, medical complications, reoperations, revisions, and implant survivorship were assessed. The mean follow-up time was 6.8 years (range, 2-21 years).
The bariatric surgery cohort had a higher rate of any complication (29.5% vs. 14.8% vs. 14.2%; P < .001), surgical complications (25.1% vs. 12.6% vs. 12.6%; P = .002), and noninfectious complications (20.2% vs. 10.4% vs. 9.8%; low P = .009 and high P = .005) relative to both low and high BMI groups. For BS patients, the 15-year survivorship free of any complication was 55.6 (95% confidence interval [CI], 43.8%-70.5%) compared with 80.3% (95% CI, 72.3%-89.3%) in the low BMI group and 75.8% (65.6%-87.7%) in the high BMI group (P < .001). Comparisons of the bariatric and matched groups demonstrated no statistical differences between the risk of reoperation or revision surgery. When SA was performed within 2 years of BS, higher rates of complications (50% vs. 27.0%; P = .030), reoperations (35.0% vs. 8.0%; P = .002), and revisions (30.0% vs. 5.5%; P = .002) were observed.
Primary shoulder arthroplasty in patients with prior bariatric surgery demonstrated an elevated complication profile when compared to matched cohorts of patients with no history of BS and either low or high BMI. These risks were more pronounced when shoulder arthroplasty was performed within 2 years of bariatric surgery. Care teams should be aware of the potential implications of the postbariatric metabolic state and investigate whether further perioperative optimization is warranted.
减重手术(BS)是治疗病态肥胖患者的一种备受争议但常用的治疗策略。尽管 BS 技术最近有所进步,但关于既往 BS 对接受肩部关节置换术患者的潜在影响的数据有限。本研究评估了既往接受 BS 的患者行初次肩部关节置换术(SA)的结果,并与匹配的对照组进行比较。
在一家机构中,在 31 年的时间内(1989 年至 2020 年)对 183 例接受过 BS 的初次 SA(12 例半髋关节置换术[HA]、59 例解剖全髋关节置换术[aTSA]和 112 例反式肩关节置换术[RSA])患者进行了评估,这些患者均有至少 2 年的随访。根据年龄、性别、诊断、植入物、美国麻醉师协会评分、Charlson 合并症指数、SA 手术年份,将该队列按 1:1:1 匹配分为无 BS 史且 BMI <40(低 BMI 组)或≥40(高 BMI 组)的 SA 对照组。评估手术并发症、医疗并发症、再次手术、翻修和植入物存活率。平均随访时间为 6.8 年(范围,2-21 年)。
BS 组的总并发症发生率(29.5%比 14.8%比 14.2%;P<.001)、手术并发症发生率(25.1%比 12.6%比 12.6%;P=.002)和非感染性并发症发生率(20.2%比 10.4%比 9.8%;低 P=0.009,高 P=0.005)均高于低和高 BMI 组。对于 BS 患者,15 年无任何并发症的存活率为 55.6%(95%可信区间[CI],43.8%-70.5%),而低 BMI 组为 80.3%(95% CI,72.3%-89.3%),高 BMI 组为 75.8%(65.6%-87.7%)(P<.001)。BS 组和匹配组之间的比较表明,再次手术或翻修手术的风险无统计学差异。当 BS 后 2 年内进行 SA 时,并发症发生率(50%比 27.0%;P=0.030)、再次手术率(35.0%比 8.0%;P=0.002)和翻修率(30.0%比 5.5%;P=0.002)更高。
与无 BS 史且 BMI 低或高的匹配对照组相比,既往 BS 的患者行初次肩部关节置换术的并发症发生率更高。当 BS 后 2 年内进行肩部关节置换术时,这些风险更为明显。治疗团队应意识到 BS 后代谢状态的潜在影响,并探讨是否需要进一步的围手术期优化。